Clicky

Inyx Inc(IYXI)

Description: Inyx, Inc., through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe. It develops and manufactures prescription and over-the-counter pharmaceutical products. The company manufactures hydrocarbon aerosols, a delivery system for dermatological and topical drug applications; metered dose inhalers that are used for respiratory conditions; dry powdered inhalers used for respiratory ailments; metered dose nasal and throat pumps, and sprays; and sterile salines and injectables. It focuses on research and development activities on inhalation-therapy drug delivery devices and inhalation methods, and generic prescription, and over-the-counter aerosol pharmaceutical products for respiratory, allergy, dermatological, and topical and cardiovascular applications. The company's proprietary products under development include generic versions of nonchlorofluorocarbon or hydrofluoroalkane single molecule and combination drug respiratory inhalants, nonCFC propelled oral sprays for cardiovascular ailments, wound irrigation, and cleansing sprays that utilize novel barrier technologies, and anti-inflammatory nasal pumps. It also provides specialty pharmaceutical development and manufacturing consulting services to the international healthcare market. The company was incorporated in 2000 and is based in New York, New York.


Keywords: Pharmaceutical Medication Pharmacology Allergy Asthma Drug Delivery Respiratory Therapy Smoking Cessation Healthcare Market Inhaler Pharmaceutical Development Metered Dose Inhaler Over The Counter Pharmaceutical Products

Home Page:

825 Third Avenue
New York, NY 10022
United States
Phone: 212-838-1111


Officers

Name Title
Mr. Steven Handley Pres & Director
Mr. Jay M. Green Exec. VP, Director of Corp. Devel. & Director
Ms. Carole Richardson Corp. Admin. Mang. of Inyx Pharma Ltd.
Mr. William Kelly VP of Corp. Communications & Investor Relations
Mr. Stephen Beckman VP of Sales & Marketing and Commercial Devel.
Norma Rosa Head of Fin. - Inyx USA Inc
Mr. Tony Weeks Head of Operations - Ashton Pharmaceuticals Ltd
Mr. Eddie Prady Head of Quality - Ashton Pharmaceuticals Ltd
Dr. Ulrich Bartke Ph.D. VP of Global Sales & Marketing

Exchange: OTCCE

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 0.0002
IPO Date:
Fiscal Year End: December
Full Time Employees: 572
Back to stocks